All medac Pharma Products

Search results

23 results

Carmustine medac

The marketing authorisation of carmustine was transferred from Obvius to medac. For a short transition period, the packaging will still show the name Carmustine Obvius

Carmustine medac is available as a powder and solvent for concentrate for solution for infusion.

Click here to view the Carmustine medac SPC

Reporting an adverse event

Apart from the desired effects, medical products can have side effects that are unpleasant or unintended. At medac, we continually collate information about side effects in order to monitor the benefit risk balance of each medication throughout its marketing lifecycle, and if necessary, can take action to better protect patient safety.

Reporting forms and information can be found at Adverse events should also be reported to medac Pharma at

We may contact you to gain further details about the report. However we are unable to provide medical advice. If you are concerned about any aspect of your treatment please discuss this with your healthcare professional (such as a doctor, nurse or pharmacist).



Please enter your email address and password to log in.